|
CN101437524A
|
|
Preparation of 2' ifluoro-2'- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
|
|
CN101023094A
|
|
Preparation of alkyl-substituted 2-deoxy-2-fluoro-d-ribofuranosyl pyrimidines and purines and their derivatives
|
|
US2004181078A1
|
|
Tetraphosphonate bicyclic trisanhydrides
|
|
AU2003290816A1
|
|
Modified nucleosides as antiviral agents
|
|
ZA200306739B
|
|
Method for the synthesis of 2',3'-dideoxy-2',3'-didehydro-nucleosides.
|
|
WO2004013298A2
|
|
2',3'-dideoxynucleoside analogues for the treatment or prevention of flavivitridae infections
|
|
MXPA04007876A
|
|
Modified fluorinated nucleoside analogues.
|
|
WO03063771A2
|
|
N4-acylcytosine nucleosides for treatment of viral iinfections
|
|
EP1461041A2
|
|
Preparation of intermediates useful in the synthesis of antiviral nucleosides
|
|
CN1505635A
|
|
Method for the synthesis of 2',3'-dideoxy-2',3'-didehydronucleosides
|
|
EP1366055A2
|
|
Antiviral agents for treatment of flaviviridae infections
|
|
TWI293306B
|
|
Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation
|
|
CA2426187A1
|
|
Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation
|
|
AU2888502A
|
|
Simultaneous quantification of nucleic acids in diseased cells
|
|
EP1238061A2
|
|
A new genotype of hepatitis b virus
|
|
EP1469003A2
|
|
Tetraphosphonate bicyclic trisanhydrides
|
|
EP0934325A1
|
|
Mycophenolic bisphosphonate compounds
|
